National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 101612 [2024-29540]
Download as PDF
<![CDATA[
101612
Federal Register / Vol. 89, No. 241 / Monday, December 16, 2024 / Notices
Address: National Institutes of Health
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Meeting Format: Virtual Meeting.
Contact Person: Andrea B. Kelly, Ph.D.,
Scientific Review Officer, National Institute
on Deafness and Other Communication
Disorders, National Institutes of Health, 6001
Executive Boulevard, Room 8351, Bethesda,
MD 20892, (301) 451–6339, kellya2@nih.gov.
Name of Committee: Communication
Disorders Review Committee.
Date: February 20–21, 2025.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: Hilton Garden Inn Orlando at
SeaWorld Orlando, FL.
Meeting Format: In Person and Virtual
Meeting.
Contact Person: Katherine Shim, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, NIDCD, NIH, 6001
Executive Blvd., Bethesda, MD 20892, 301–
496–8683, shimk@nidcd.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: December 11, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–29558 Filed 12–13–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
lotter on DSK11XQN23PROD with NOTICES1
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting of the National
Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; P41 NCBIB Review
D–SEP.
Date: March 4–7, 2024.
Time: 9:00 a.m. to 1:00 p.m.
VerDate Sep<11>2014
17:41 Dec 13, 2024
Jkt 265001
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Democracy II, Suite 920, 6707 Democracy
Blvd., Bethesda, MD 20817 (Virtual Meeting).
Contact Person: John Hayes, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Bethesda, MD 20892, (301)
451–3398, john.hayes@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, National Institute of
Biomedical Imaging and Bioengineering,
National Institutes of Health.)
Dated: December 11, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: December 11, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–29540 Filed 12–13–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
[FR Doc. 2024–29551 Filed 12–13–24; 8:45 am]
National Library of Medicine; Notice of
Meetings
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; Trial Net Hub and
Coordinating Center Cooperative Agreement
(U01) Application Review.
Date: February 28, 2025.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
National Institute of Diabetes and Digestive
and Kidney Diseases, Democracy II, Suite
7000A, 6707 Democracy Boulevard,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Cheryl Nordstrom, Ph.D.,
MPH, Scientific Review Officer, Scientific
Review Branch, National Institute of Diabetes
and Digestive and Kidney Diseases, National
Institutes of Health, 6707 Democracy
Boulevard, Room 7013, Bethesda, MD 20892,
301–402–6711, cheryl.nordstrom@nih.gov.
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting.
The meeting will be open to the
public as indicated below. Individuals
who plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations should notify the
Contact Person listed below in advance
of the meeting.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), title 5 U.S.C., as amended for
review, discussion, and evaluation of
individual intramural programs and
projects conducted by the National
Library of Medicine, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Library of
Medicine Board of Scientific Counselors.
Date: April 30, 2025.
Open: 9:00 a.m. to 10:20 p.m.
Agenda: Program Discussion and
Investigator Report.
Closed: 10:20 p.m. to 11:45 a.m.
Agenda: To review and evaluate personal
qualifications, performance, and competence
of individual investigators.
Open: 11:45 a.m. to 12:30 p.m.
Agenda: Program Discussion and
Investigator Report.
Closed: 12:30 p.m. to 2:00 p.m.
Agenda: To review and evaluate personal
qualifications, performance, and competence
of individual investigators.
Open: 2:00 p.m. to 2:45 p.m.
Agenda: Program Discussion and
Investigator Report.
Place: National Library of Medicine, 8600
Rockville Pike, Bethesda, MD 20892 (Inperson and Virtual Meeting).
E:\FR\FM\16DEN1.SGM
16DEN1
]]>Agencies
[Federal Register Volume 89, Number 241 (Monday, December 16, 2024)]
[Notices]
[Page 101612]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-29540]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Diabetes and Digestive
and Kidney Diseases Special Emphasis Panel; Trial Net Hub and
Coordinating Center Cooperative Agreement (U01) Application Review.
Date: February 28, 2025.
Time: 12:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, National Institute of
Diabetes and Digestive and Kidney Diseases, Democracy II, Suite
7000A, 6707 Democracy Boulevard, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Cheryl Nordstrom, Ph.D., MPH, Scientific Review
Officer, Scientific Review Branch, National Institute of Diabetes
and Digestive and Kidney Diseases, National Institutes of Health,
6707 Democracy Boulevard, Room 7013, Bethesda, MD 20892, 301-402-
6711, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes of Health, HHS)
Dated: December 11, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-29540 Filed 12-13-24; 8:45 am]
BILLING CODE 4140-01-P
